Herti 150mg

Herti 150 is a prescription medication used to treat certain types of breast cancer, including:

• HER2-positive breast cancer (in combination with chemotherapy)
• HER2-positive metastatic breast cancer (in combination with chemotherapy)

Composition:

Herti 150 is a single-ingredient product containing Trastuzumab, a humanized monoclonal antibody that targets the human epidermal growth factor receptor 2 (HER2).

Mechanism of Action:

Trastuzumab works by binding to the HER2 protein on the surface of cancer cells, which inhibits the growth and survival of these cells. Trastuzumab also inhibits the formation of new blood vessels that supply the cancer cells with oxygen and nutrients.

Uses:

Herti 150 is used to treat:

• HER2-positive breast cancer in combination with chemotherapy (in early-stage breast cancer)
• HER2-positive metastatic breast cancer in combination with chemotherapy (in advanced breast cancer)

Dosage:

The recommended dosage of Herti 150 is:

• 150mg administered as an intravenous infusion every 21 days
• Continue treatment until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Herti 150 include:

• Fever
• Chills
• Fatigue
• Headache
• Nausea
• Vomiting
• Diarrhea
• Increased risk of heart failure
• Decreased platelet count
• Decreased white blood cell count
• Increased risk of bleeding

Recommendation:

Herti 150 is recommended for patients with HER2-positive breast cancer who have not received previous chemotherapy for this condition. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.

Important Note:

Patients should not take Herti 150 if they have a history of severe allergic reactions, heart problems, or kidney problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as hypertension or thyroid problems, before taking Herti 150.

Please note that Herti 150 is not available in all markets and may be approved for different indications and dosages in different regions.